PLUS THERAPEUTICS INC (PSTV) Stock Earnings & Estimates
NASDAQ:PSTV - US72941H5090 - Common Stock
0.4699 USD
+0.01 (+1.69%)
0.4699 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 220K | 4.913M 2,133.18% | 5.824M 18.54% | 5.996M 2.95% | 6.469M 7.89% | 23.041M 256.18% | 48.09M 108.71% | 136.18M 183.18% | 189.98M 39.51% | 345.48M 81.85% | 642.87M 86.08% | |
| EBITDA YoY % growth | -19.09M -62.19% | -12.693M 33.51% | -13.972M -10.08% | -12.24M 12.40% | -15.096M -23.33% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -19.71M -61.96% | -13.321M 32.42% | -14.695M -10.31% | -9.126M 37.90% | -15.222M -66.80% | -10.291M 32.39% | -608.257K 94.09% | 64.436M 10,693.56% | 105.19M 63.25% | 222.64M 111.66% | 470.7M 111.42% | |
| Operating Margin | -8,959.09% | -271.14% | -252.32% | -152.20% | -235.31% | -44.67% | -1.26% | 47.32% | 55.37% | 64.44% | 73.22% | |
| EPS YoY % growth | -12.60 -1,015.04% | -4.53 64.05% | -2.17 52.10% | -0.67 69.13% | -0.36 46.70% | -0.11 68.57% | -0.03 72.73% | 0.30 1,066.67% | 0.51 72.41% | 1.23 142.00% | 1.96 58.68% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 94.49% | -0.02 96.88% | -0.03 97.86% | -0.03 -227.50% | -0.08 -300.00% | -0.07 -388.87% |
| Revenue Q2Q % growth | 1.666M 14.42% | 1.964M 39.09% | 1.891M 78.56% | 2.071M 48.99% | 1.636M -1.80% | 1.955M -0.46% |
| EBITDA Q2Q % growth | -2.856M 12.79% | -3.264M -2.74% | -3.774M -11.33% | -3.774M -187.00% | -3.774M -32.14% | -3.774M -15.63% |
| EBIT Q2Q % growth | -1.746M 54.05% | -1.733M 55.57% | -4.492M -27.04% | -4.687M -204.74% | -4.834M -176.92% | -4.931M -184.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.02 103.57% | -0.09 | 0.11 | 121.79% |
| Q1 2025 Q2Q % growth | -1.19 -58.67% | -0.15 | -1.04 | -695.44% |
| Q4 2024 Q2Q % growth | -0.49 41.67% | -0.51 | 0.02 | 3.28% |
| Q3 2024 Q2Q % growth | -0.37 63.00% | -0.57 | 0.20 | 35.51% |
| Q2 2024 Q2Q % growth | -0.56 5.08% | -0.54 | -0.02 | -3.59% |
| Q1 2024 Q2Q % growth | -0.75 64.29% | -1.11 | 0.36 | 32.54% |
| Q4 2023 Q2Q % growth | -0.84 74.55% | -1.09 | 0.25 | 23.21% |
| Q3 2023 Q2Q % growth | -1.00 64.91% | -1.14 | 0.14 | 12.66% |
| Q2 2023 Q2Q % growth | -0.59 83.61% | -1.95 | 1.36 | 69.79% |
| Q1 2023 Q2Q % growth | -2.10 26.32% | -1.94 | -0.16 | -8.36% |
| Q4 2022 Q2Q % growth | -3.30 -1,122.22% | -1.84 | -1.46 | -79.74% |
| Q3 2022 Q2Q % growth | -2.85 -917.86% | -3.10 | 0.25 | 8.01% |
| Q2 2022 Q2Q % growth | -3.60 -1,340.00% | -3.32 | -0.28 | -8.60% |
| Q1 2022 Q2Q % growth | -2.85 -763.64% | -2.75 | -0.10 | -3.49% |
| Q4 2021 Q2Q % growth | -0.27 59.58% | -0.28 | 0.01 | 1.96% |
| Q3 2021 Q2Q % growth | -0.28 28.21% | -0.25 | -0.03 | -12.81% |
| Q2 2021 Q2Q % growth | -0.25 3.85% | -0.24 | -0.01 | -2.12% |
| Q1 2021 Q2Q % growth | -0.33 -17.86% | -0.35 | 0.02 | 5.54% |
| Q4 2020 Q2Q % growth | -0.67 -390.43% | -0.40 | -0.27 | -65.80% |
| Q3 2020 Q2Q % growth | -0.39 -1,200.00% | -0.56 | 0.17 | 30.48% |
| Q2 2020 Q2Q % growth | -0.26 94.92% | -0.77 | 0.51 | 66.01% |
| Q1 2020 Q2Q % growth | -0.28 99.94% | -0.77 | 0.49 | 63.40% |
| Q4 2019 Q2Q % growth | 0.23 | -0.67 | 0.90 | 134.17% |
| Q3 2019 Q2Q % growth | -0.03 | -5.97 | 5.94 | 99.50% |
| Q2 2019 Q2Q % growth | -5.12 | -497.25 | 492.13 | 98.97% |
| Q1 2019 Q2Q % growth | -450.00 | -510.00 | 60.00 | 11.76% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.39M 8.68% | 1.516M | -126K | -8.31% |
| Q1 2025 Q2Q % growth | 1.059M -36.85% | 1.513M | -454K | -30.01% |
| Q4 2024 Q2Q % growth | 1.412M 7.54% | 1.027M | 385K | 37.49% |
| Q3 2024 Q2Q % growth | 1.456M 17.42% | 1.547M | -91K | -5.88% |
| Q2 2024 Q2Q % growth | 1.279M -31.01% | 1.709M | -430K | -25.16% |
| Q1 2024 Q2Q % growth | 1.677M 228.82% | 1.721M | -44K | -2.56% |
| Q4 2023 Q2Q % growth | 1.313M 775.33% | 1.084M | 229K | 21.13% |
| Q3 2023 Q2Q % growth | 1.24M 1,671.43% | 1.319M | -79K | -5.99% |
| Q2 2023 Q2Q % growth | 1.854M | 805.545K | 1.048M | 130.15% |
| Q1 2023 Q2Q % growth | 510K | 756.503K | -246.503K | -32.58% |
| Q4 2022 Q2Q % growth | 150K | 1.293M | -1.143M | -88.40% |
| Q3 2022 Q2Q % growth | 70K | 235.875K | -165.875K | -70.32% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 190K -36.67% | 190K | % | |
| Q1 2020 Q2Q % growth | 120K -83.78% | 120K | % | |
| Q2 2019 Q2Q % growth | 300K | 1.38M | -1.08M | -78.26% |
| Q1 2019 Q2Q % growth | 740K | 1.735M | -995K | -57.35% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 76% | 94.12% | 16.88% | 22.97% |
| Revenue | -10.57% | 40% | -4.9% | -9.1% |